Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03562637
Title Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors OBI Pharma, Inc
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.